Feuchtenberger, Martin http://orcid.org/0000-0001-8028-8099
Kraus, Lisa http://orcid.org/0000-0002-8113-4849
Nigg, Axel http://orcid.org/0000-0001-5805-806X
Schulze-Koops, Hendrik
Schäfer, Arne http://orcid.org/0000-0001-6600-3691
Article History
Received: 28 December 2020
Accepted: 2 February 2021
First Online: 20 February 2021
Compliance with ethical standards
:
: Dr. Feuchtenberger reports personal fees from AbbVie, personal fees from Roche, personal fees from UCB, outside the submitted work. Dr. Kraus has nothing to disclose. Dr. Schäfer reports personal fees from Novo Nordisk Pharma GmbH, outside the submitted work. Dr. Nigg has nothing to disclose. Dr. Schulze-Koops has nothing to disclose.
: The observational study was approved by the ethics committee of the University of Würzburg, Germany, on 12 July 2018.
: All patients provided written informed consent for liver elastometry measurements, study participation and publication of data.
: The revised paper has been read and approved by all authors.